Literature DB >> 9925168

Drug prohibition and public health: 25 years of evidence.

E Drucker1.   

Abstract

FOR THE PAST 25 YEARS, the US has pursued a drug policy based on prohibition and the vigorous application of criminal sanctions for the use and sale of illicit drugs. The relationship of a prohibition-based drug policy to prevalence patterns and health consequences of drug use has never been fully evaluated. To explore that relationship, the author examines national data on the application of criminal penalties for illegal drugs and associated trends in their patterns of use and adverse health outcomes for 1972-1997.Over this 25-year period, the rate at which criminal penalties are imposed for drug offenses has climbed steadily, reaching 1.5 million arrests for drug offenses in 1996, with a tenfold increase in imprisonment for drug charges since 1979. Today, drug enforcement activities constitute 67% of the $16 billion Federal drug budget and more than $20 billion per year in state and local enforcement expenditures, compared with $7.6 billion for treatment, prevention, and research.Despite an overall decline in the prevalence of drug use since 1979, we have seen dramatic increases in drugrelated emergency department visits and drug-related deaths coinciding with this period of increased enforcement.Further, while black, Hispanic, and white Americans use illegal drugs at comparable rates, there are dramatic differences in the application of criminal penalties for drug offenses. African Americans are more than 20 times as likely as whites to be incarcerated for drug offenses, and drug-related emergency department visits, overdose deaths, and new HIV infections related to injecting drugs are many times higher for blacks than whites.These outcomes may be understood as public health consequences of policies that criminalize and marginalize drug users and increase drug-related risks to life and health.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925168      PMCID: PMC1308340          DOI: 10.1093/phr/114.1.14

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  3 in total

Review 1.  Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.

Authors:  E Drucker; P Lurie; A Wodak; P Alcabes
Journal:  AIDS       Date:  1998       Impact factor: 4.177

2.  An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA.

Authors:  P Lurie; E Drucker
Journal:  Lancet       Date:  1997-03-01       Impact factor: 79.321

3.  Poisoning mortality, 1985-1995.

Authors:  L A Fingerhut; C S Cox
Journal:  Public Health Rep       Date:  1998 May-Jun       Impact factor: 2.792

  3 in total
  25 in total

1.  Early and mid-adolescence risk factors for later substance abuse by African Americans and European Americans.

Authors:  Andres G Gil; William A Vega; R Jay Turner
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

2.  Displacement of Canada's largest public illicit drug market in response to a police crackdown.

Authors:  Evan Wood; Patricia M Spittal; Will Small; Thomas Kerr; Kathy Li; Robert S Hogg; Mark W Tyndall; Julio S G Montaner; Martin T Schechter
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

3.  Associations between early-adolescent substance use and subsequent young-adult substance use disorders and psychiatric disorders among a multiethnic male sample in South Florida.

Authors:  Andres G Gil; Eric F Wagner; Jonathan G Tubman
Journal:  Am J Public Health       Date:  2004-09       Impact factor: 9.308

4.  Adolescent substance use and other illegal behaviors and racial disparities in criminal justice system involvement: findings from a US national survey.

Authors:  Meghana Kakade; Cristiane S Duarte; Xinhua Liu; Cordelia J Fuller; Ernest Drucker; Christina W Hoven; Bin Fan; Ping Wu
Journal:  Am J Public Health       Date:  2012-05-17       Impact factor: 9.308

5.  Dealing with prostitution in Canada.

Authors:  Benedikt Fischer
Journal:  CMAJ       Date:  2005-01-04       Impact factor: 8.262

6.  Attitudes and practices regarding the use of methadone in US state and federal prisons.

Authors:  Josiah D Rich; Amy E Boutwell; David C Shield; R Garrett Key; Michelle McKenzie; Jennifer G Clarke; Peter D Friedmann
Journal:  J Urban Health       Date:  2005-05-25       Impact factor: 3.671

7.  Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas.

Authors:  Hannah L F Cooper; Samuel R Friedman; Barbara Tempalski; Risa Friedman
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

8.  Factors related to correctional facility incarceration among active injection drug users in Baltimore, MD.

Authors:  Stevan Geoffrey Severtson; William W Latimer
Journal:  Drug Alcohol Depend       Date:  2007-12-21       Impact factor: 4.492

9.  Prisoners favour hepatitis C testing and treatment.

Authors:  S Vallabhaneni; G E Macalino; S E Reinert; B Schwartzapfel; F A Wolf; J D Rich
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

10.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.